Abo System
Abo System - Related Videos
01:12
The ABO Blood Group
0 Views •
2024
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma. Antigens in the ABO Blood Group System Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
15:05
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
0 Views •
Cited by 7 •
2020
The objective of this protocol is to use molecular dynamics simulations to examine the dynamic structural changes that occur due to activating mutations of the EGFR kinase protein.
07:02
Generating 3D Spheres and 2D Air-Liquid Interface Cultures of Human Induced Pluripotent Stem Cell-Derived Type 2 Alveolar Epithelial Cells
0 Views •
Cited by 8 •
2022
The present protocol describes human induced pluripotent stem cell-derived type 2 alveolar epithelial-like cells (iAT2s). These cells can be cultured as self-renewing spheres in 3D culture or adapted to air-liquid interface (ALI) culture.
10:00
2.5D Model for Ex Vivo Mechanical Characterization of Sprouting Angiogenesis in Living Tissue
0 Views •
2025
Sprouting angiogenesis, fundamental for development and disease, involves complex molecular and mechanical processes. We present a versatile 2.5D ex vivo model that analyzes cellular sprouting from porcine carotid arteries, revealing stiffness-dependent angiogenesis and distinct leader-follower cell mechanics. This model aids in advancing tissue engineering strategies and cancer therapy approaches.
05:32
High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
0 Views •
Cited by 2 •
2022
High-speed video microscopy analysis is a relatively easy-to-perform, fast, cost-effective, and, in experienced hands, a considerably reliable tool for first-line diagnostics of primary ciliary dyskinesia, which should be available in every center involved in diagnostics and the treatment of severe lung diseases.
FAQs
The inherited allele determines which glycosyltransferase activity is available on red-cell precursors. An active A-associated enzyme modifies the H antigen into an A structure, whereas the B-associated enzyme produces a B structure. The O allele generally encodes an inactive enzyme, so the H antigen remains unchanged. These molecular differences generate distinct ABO phenotypes.
The H antigen is the shared starting structure that the A- and B-associated glycosyltransferases modify. Its state therefore reveals the consequence of inherited enzyme activity: modification yields an A or B structure, while an inactive O-associated enzyme leaves it unchanged. This relationship connects molecular genetics with the antigen pattern observed on red cells.
ABO antibodies can bind to the corresponding antigen on incompatible red cells. Because people typically form antibodies against ABO antigens they lack, the recipient's plasma may recognize transfused cells as incompatible. This interaction can trigger rapid agglutination, meaning cell clumping, and hemolysis, the destruction of red cells. Compatibility is therefore a critical biological issue, not merely a labeling convention.
ABO interpretation requires attention to two linked features: the antigens displayed by red cells and the naturally occurring antibodies present in plasma. An individual typically lacks antibodies against the antigens they possess but forms antibodies against those absent. Considering both patterns explains why donor and recipient antigen-antibody profiles must be compared when assessing transfusion compatibility.
ABO typing translates the biological antigen pattern into information that can guide transfusion decisions. By identifying the relevant ABO group, it helps practitioners compare a recipient's compatibility requirements with the blood being considered. The determination provides one part of the compatibility assessment used with crossmatching to support safe red-cell transfusion and avoid incompatible exposure.
Crossmatching complements ABO typing by focusing on whether the proposed donor-recipient pairing is suitable for transfusion. A blood-group result supplies classification information, whereas crossmatching supports the practical compatibility decision for the specific transfusion context. Using these approaches together strengthens transfusion safety because incompatible red-cell exposure can lead to agglutination and hemolysis.
ABO compatibility extends beyond transfused red cells because transplantation also depends on how blood-group antigens and antibodies may interact between donor and recipient. Consequently, the Abo System informs compatibility assessment when organs are considered for transplantation. Its application differs from routine blood typing, but the same antigen-antibody biology provides the immunohematologic context for evaluating potential matches.
In biology, the Abo System connects molecular genetics with observable variation in blood cells. Researchers can relate inherited alleles and their encoded glycosyltransferases to the presence or absence of A and B structures, while immunohematology examines the corresponding plasma antibodies and compatibility consequences. This makes the system useful for studying blood-group genetics and clinically relevant antigen-antibody relationships.